Canadian Cancer Society (CCS)
For More Information
For additional information, please visit the CCS funding website.
CCS’s Research Goals to 2040 are:
- Prevent – fewer people in Canada will develop cancer
- Detect – fewer people will be diagnosed with Stage 3 or Stage 4 cancer
- Care – people with cancer will live longer and with improved quality of life during and after treatment
- Champion – equitable and timely access to innovative and affordable high-quality care for more people in Canada
Challenges should align with CCS Research Goals and applicants must clearly articulate how and/or why the challenge is relevant to people affected by cancer (or, for prevention-focused research, at risk of cancer). Applicants must clearly describe the anticipated contribution of their proposed project towards solving the identified challenge. This includes, for example, outcomes that have immediate impact (such as a device, therapeutic, program, policy or practice change) or those that are more long term in scope (such as an important finding relevant to the biology or etiology of cancer that could eventually be applied to prevent cancer or improve outcomes). Applicants will describe how the knowledge generated through these grants will be shared and/or mobilized to ensure implementation of next steps.
- Abstract registrations due: June 21, 2023
- Relevance review results*: mid-July, 2023
- Full applications due: September 21, 2023
- Results announcement: January 2024
- Funding start date: January 1, 2024
*Abstract submissions will undergo a relevance review process to ensure alignment with the Challenge Grants program (i.e. clear identification of a challenge that is demonstrably meaningful to people affected by or at risk of cancer).
Up to $18M is available in this competition to fund grants of up to $175k/yr over 3 years